Latest cancer patients News | Page 7

More medicines for more New Zealanders
Dot’s Place Bunbury celebrates 10-year anniversary
Eight year old Maisie climbs mountains for those affected by cancer
How you helped us this year
Karen’s home away from home for Christmas
Hopetoun champion becomes face of our Christmas Appeal
IND approval from US FDA for theranostic SARBombesin trial in prostate cancer
ANU researchers win PM’s science prizes
Dot’s Place Peel celebrates five year anniversary
Tumour matrix profiling gives clues to progression of some l
Ludwig Cancer Research study finds common, targetable mechanism tumors use to suppress immune responses
Researchers discover breast cancer protein could predict chemotherapy sensitivity
Brightest cancer researchers WEHI teams awarded new funding grants
Olive’s million-dollar gift to regional Queenslanders
Are you up for Challenge?
Exercise protects breast cancer patients hearts against chemotherapy drugs, new study finds
Vaccination with senescent cells reduced tumor formation in mice
Free first consult for all patients at UC Cancer Wellness Clinic, thanks to Capital Chemist Group donation
Crucial program changing lives of regional patients
NSW new crucial program changing lives of regional patients
Funding Boost Supporting Cancer Research Leaders
Starting cancer treatment? You should discuss fertility first
World-first brain cancer clinical trials launched in Melbourne
Camizestrant significantly improved progression-free survival in advanced ER-positive breast cancer
Capivasertib Phase III trial met primary endpoints
Aged care reform starts to deliver for palliative care patients
What are postbiotics and how can they improve our gut health?
Gene signature points to prognosis in kidney cancer
Collaborative brain cancer research awarded $4.6m grant
ESMO 2022: Clinical trial updates
$5.4 million boost for brain cancer research
Ground-breaking platform launched for Aboriginal and Torres Strait Islander people affected by cancer
Council shines light on breast cancer awareness
Second fast-track designation for Australian immunotherapy company
Singaporean Healthtech Leader Sets Up In Melbourne
New epigenetic markers for prostate cancer discovered
4 researchers striving to reduce impact of childhood cancer in our community
New agreement on detection and diagnosis of health conditions across Greater Manchester
Ask us anything. Prostate cancer
EpiAxis Therapeutics announces collaboration with Canadian research hospital
Our home-away-from-home for regional cancer patients
Research Team Creates More Effective Cancer Therapy
Cancer self-treatment concern
Blood stem cell research that could change medicine of future
Imfinzi and tremelimumab with chemotherapy demonstrated sustained survival benefit
Tagrisso demonstrated 5.5-year median disease-free survival in adjuvant treatment of patients with EGFR-mutated lung cancer
Lynparza in combination with bevacizumab, and as monotherapy, demonstrates clinically meaningful survival benefit
New research highlights importance of screening for breast cancer patients